Unleashing the power of immune cell interactions

Cancer immunotherapy fails in 80% of patients due to break down in immune cell interactions. Our proprietary discovery platform learns how a multitude of critical immune cell interactions break down in patient tumors using advanced genomics and microscopy.

We design first-in-class therapeutics to engage immune cells and restore critical interactions, delivering radically improved treatment efficacy for over a third of the patients who fail to respond to current cancer immunotherapies, representing an over $100B opportunity.

Voyant Bio Selected for Merck Digital Sciences Studio

Voyant Bio is proud to announce its acceptance into the latest cohort of the Merck Digital Sciences Studio (MDS Studio), a digital accelerator designed to enable the next generation of technologies for drug discovery and development, including artificial intelligence and machine learning. MDS Studio was founded to offer support for early-stage biomedical startups providing strategic guidance, direct investment, and connection opportunities within Merck.

About Merck Digital Sciences Studio
The Merck Digital Sciences Studio (MDS Studio or MDSS), a collaboration between Merck, Merck Global Health Innovation Fund, Northpond Ventures, McKesson Ventures, Microsoft for Startups, and the New Jersey Innovation Institute, a New Jersey Institute of Technology (NJIT) subsidiary. The 10-month startup accelerator program, with direct investments from Merck Global Health Innovation Fund, Northpond Ventures, and McKesson Ventures, empowers members and enables the generation of innovative digital technologies for drug discovery and development through hands-on mentorship, connection opportunities with industry-leading partners, and training in an active entrepreneurial setting. Through the accelerator program, these startups will have access to workshops, coaching, office space, and Microsoft for Startups Founders Hub resources, including up to $150,000 Azure Cloud computing credits.

Leadership

Assaf Magen, Ph.D., CEO & CSO

Voyant is led by an established team including Assaf Magen, PhD, CEO & CSO, an expert in immuno-oncology and computational biology, inventor of the technology, and lead author of a seminal publication. Together with a world-class biopharma advisory team, we are uniquely positioned to make breakthroughs in immuno-oncology.

Founding computational biologist role

About Us: Voyant Bio has developed a spatial biology platform to unleash immunity against multiple cancers by rewiring immune cell interactions. Our first-in-class therapeutics have the potential to radically improve treatment efficacy for the 80% of patients who fail to respond to cancer immunotherapies. We are a backed by Merck Digital Sciences Studio.Who We Are: Our team is led by Assaf Magen, PhD, CEO, an expert in immuno-oncology and computational biology, inventor of the technology, and lead author of a seminal publication. He trained at the National Cancer Institute (NCI, NIH) and was an assistant professor at Mount Sinai. Together with a world-class biopharma advisory team, we are uniquely positioned to make breakthroughs in immuno-oncology.The Role: We are looking for a founding Machine Learning/Computational Biology scientist to lead our technical efforts, focusing on multi-modal single-cell geomics, spatial data analysis, and method development. You’ll be instrumental in shaping the bioinformatics roadmap and building scalable platforms and generative models for diverse biological datasets.
This role requires hands-on experience in Python for microscopy data analysis and single-cell genomics, as well as expertise in large-scale data management in cloud environments. A strong foundation in AI-driven approaches to biological data interpretation and modeling is essential. Ideally, you have recruited, managed, and led a computational biology or machine learning team. Exposure to immunology or immuno-oncology is a plus.This is a founding scientist position with incredible room for growth in responsibilities and benefits as we grow.Please use the form below. No recruiters, please. We are unable to sponsor visas at this time.

Voyant Bio
Unleashing effective immunity against cancer by rewiring immune-immune cell interactions.

© Voyant Bio. All rights reserved.